What must be considered when deciding whether to continue breastfeeding during inclisiran sodium treatment?

For inclisiran sodium (Leqvio), deciding whether to stop breastfeeding or discontinue/abstain from therapy requires weighing breastfeeding benefits for the child and treatment benefits for the woman, as human milk excretion is unknown, animal milk excretion occurs, and risk to newborns/infants cannot be excluded.